The Maudsley Prescribing Guidelines in Psychiatry / (Record no. 40748)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01836cam a22002655i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 21945006 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260319104134.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210315s2021 nju 000 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781119772231 |
| Qualifying information | (epub) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DLC |
| Language of cataloging | eng |
| Description conventions | rda |
| Transcribing agency | DLC |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | pcc |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC 483 |
| Item number | .T39 2021 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Taylor, David, |
| Dates associated with a name | 1963- |
| Relator term | author. |
| 245 14 - TITLE STATEMENT | |
| Title | The Maudsley Prescribing Guidelines in Psychiatry / |
| Statement of responsibility, etc. | David M. Taylor, Thomas R. E Barnes, Allan H. Young. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 14th Edition |
| 263 ## - PROJECTED PUBLICATION DATE | |
| Projected publication date | 2104 |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Hoboken : |
| Name of producer, publisher, distributor, manufacturer | John Wiley & Sons, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2021. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | pages cm |
| 490 0# - SERIES STATEMENT | |
| Series statement | The Maudsley prescribing guidelines series |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "This 14th edition of The Guidelines has been written under extraordinary circumstances: the coronavirus pandemic. This global phenomenon has radically altered the lives and working practices of billions of people and most of us are now familiar, either personally or vicariously, with the experience of the serious physical illness that is associated with COVID-19. Those working in healthcare have been particularly grievously affected, caring for those made ill by the disease while risking infection themselves. In this environment, the writing of a book has an extremely low priority, if any at all. It is in this context that I give boundless and sincere thanks to all those who have contributed to this edition of The Guidelines under such challenging conditions. Of course, mental health problems have not gone away during the pandemic, and the optimal treatment of mental illness remains a vital imperative. This objective will be all the more critical as we come to deal with the mental health consequences of the pandemic"-- |
| Assigning source | Provided by publisher. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drugs |
| General subdivision | Prescribing. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Young, Allan H., |
| Relator term | author. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| -- | IBS |
| Koha item type | Books |
| Date last seen | Total checkouts | Full call number | Price effective from | Koha item type | Lost status | Damaged status | Not for loan | Withdrawn status | Home library | Current library | Date acquired |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/19/2026 | RC 483 .T39 2021 | 03/19/2026 | Books | Dr. Abdul Qadeer Khan Institute of Behavioral Sciences | Dr. Abdul Qadeer Khan Institute of Behavioral Sciences | 03/19/2026 |